West to Host Third-Quarter 2024 Conference Call
West Pharmaceutical Services (NYSE: WST) has announced its upcoming third-quarter 2024 financial results release and conference call. The company, a global leader in injectable drug administration solutions, will disclose its results before the market opens on Thursday, October 24, 2024. This will be followed by a conference call at 9:00 a.m. Eastern Time to discuss the results and business expectations.
Interested parties can access the live webcast through the company's Investor Relations website. To participate in the Q&A session, attendees must register in advance to receive dial-in information and a unique PIN. A slide presentation will be available on the day of the call in the Investors section of West's website. For those unable to attend live, a replay of the conference call and webcast will be accessible on the company's website for approximately 90 days after the event.
West Pharmaceutical Services (NYSE: WST) ha annunciato il rilascio dei risultati finanziari del terzo trimestre del 2024 e della relativa conferenza. L'azienda, leader globale nelle soluzioni per la somministrazione di farmaci iniettabili, divulgherà i risultati prima dell'apertura del mercato giovedì 24 ottobre 2024. Seguirà una conferenza telefonica alle 9:00 a.m. Eastern Time per discutere i risultati e le aspettative aziendali.
Le parti interessate possono accedere al webcast dal vivo tramite il sito web delle Relazioni con gli Investitori dell'azienda. Per partecipare alla sessione di domande e risposte, i partecipanti devono registrarsi in anticipo per ricevere le informazioni per la telefonata e un PIN unico. Una presentazione con le diapositive sarà disponibile il giorno della chiamata nella sezione Investitori del sito di West. Per coloro che non possono partecipare dal vivo, un ripasso della conferenza e del webcast sarà accessibile sul sito dell'azienda per circa 90 giorni dopo l'evento.
West Pharmaceutical Services (NYSE: WST) ha anunciado la próxima publicación de sus resultados financieros del tercer trimestre de 2024 y la conferencia telefónica correspondiente. La compañía, un líder global en soluciones de administración de medicamentos inyectables, dará a conocer sus resultados antes de la apertura del mercado el jueves 24 de octubre de 2024. Esto será seguido por una conferencia telefónica a las 9:00 a.m. hora del Este para discutir los resultados y las expectativas comerciales.
Las partes interesadas pueden acceder al webcast en vivo a través del sitio web de Relaciones con Inversores de la compañía. Para participar en la sesión de preguntas y respuestas, los asistentes deben registrarse con anticipación para recibir la información de acceso y un PIN único. Una presentación en diapositivas estará disponible el día de la llamada en la sección de Inversores del sitio web de West. Para aquellos que no puedan asistir en vivo, una repetición de la conferencia telefónica y del webcast estará accesible en el sitio web de la empresa durante aproximadamente 90 días después del evento.
웨스트 제약 서비스 (NYSE: WST)는 2024년 3분기 재무 결과 발표 및 컨퍼런스 콜 일정을 발표했습니다. 주사제 투여 솔루션 분야의 글로벌 선두주자인 회사는 2024년 10월 24일 목요일 시장 개장 전에 결과를 공개할 예정입니다. 이후 오전 9:00 동부 표준시에 결과 및 비즈니스 기대에 대해 논의하는 컨퍼런스 콜이 진행됩니다.
관심 있는 분들은 회사의 투자자 관계 웹사이트를 통해 실시간 웹캐스트에 접속할 수 있습니다. Q&A 세션에 참여하려면 참석자는 사전 등록을 통해 다이얼인 정보와 고유한 PIN을 받아야 합니다. 컨퍼런스 콜 당일에는 웨스트의 웹사이트 투자자 섹션에 슬라이드 프레젠테이션이 제공될 것입니다. 실시간 참석이 불가능한 경우, 컨퍼런스 콜 및 웹캐스트의 재생은 사건 후 약 90일 동안 회사 웹사이트에서 접근할 수 있습니다.
West Pharmaceutical Services (NYSE: WST) a annoncé la publication de ses résultats financiers pour le troisième trimestre de 2024 et la conférence qui l'accompagne. L'entreprise, un leader mondial dans les solutions d'administration de médicaments injectables, annoncera ses résultats avant l'ouverture des marchés le jeudi 24 octobre 2024. Cela sera suivi d'une conférence téléphonique à 9h00 heure de l'Est pour discuter des résultats et des attentes commerciales.
Les parties intéressées peuvent accéder au webinaire en direct via le site Web des Relations Investisseurs de l'entreprise. Pour participer à la session de questions-réponses, les participants doivent s'inscrire à l'avance pour recevoir les informations d'appel et un code PIN unique. Une présentation PowerPoint sera disponible le jour de l'appel dans la section Investisseurs du site Web de West. Pour ceux qui ne peuvent pas assister en direct, une répétition de la conférence téléphonique et du webinaire sera accessible sur le site de l'entreprise pendant environ 90 jours après l'événement.
West Pharmaceutical Services (NYSE: WST) hat die bevorstehende Veröffentlichung der Finanzzahlen für das dritte Quartal 2024 sowie die zugehörige Telefonkonferenz angekündigt. Das Unternehmen, ein weltweit führender Anbieter von Spritzenlösungen für die Medikamentenverabreichung, wird seine Ergebnisse am Donnerstag, den 24. Oktober 2024, vor Öffnung der Märkte bekannt geben. Dies wird gefolgt von einer Telefonkonferenz um 9:00 Uhr Eastern Time, um die Ergebnisse und Geschäftserwartungen zu diskutieren.
Interessierte Parteien können über die Investor Relations-Website des Unternehmens auf den Live-Webcast zugreifen. Um an der Q&A-Sitzung teilzunehmen, müssen die Teilnehmer sich im Voraus registrieren, um Einwahlinformationen und eine individuelle PIN zu erhalten. Eine Folienpräsentation wird am Tag der Telefonkonferenz im Bereich Investoren auf der Website von West verfügbar sein. Für diejenigen, die nicht live teilnehmen können, wird eine Wiederholung der Telefonkonferenz und des Webcasts etwa 90 Tage nach der Veranstaltung auf der Unternehmenswebsite zugänglich sein.
- None.
- None.
The live webcast will be made available via the Company's Investor Relations website click here.
To ask questions on the conference call, participants need to register in advance by clicking here. Registered telephone participants will receive the dial-in number along with a unique PIN number that will enable them to ask questions on the call.
A slide presentation will be made available on the day of the call in the Investors section of the Company's website. A replay of the conference call and webcast will be available on the Company's website. Replay of the webcasts will be available for approximately 90 days after the events.
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-host-third-quarter-2024-conference-call-302272228.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
When will West Pharmaceutical Services (WST) release its Q3 2024 financial results?
What time is West Pharmaceutical Services' (WST) Q3 2024 earnings call scheduled for?
How can investors participate in West Pharmaceutical Services' (WST) Q3 2024 earnings call?
Will there be a replay available for West Pharmaceutical Services' (WST) Q3 2024 earnings call?
